DIABETIC PERIPHERAL NEUROPATHIC PAIN
Clinical trials for DIABETIC PERIPHERAL NEUROPATHIC PAIN explained in plain language.
Never miss a new study
Get alerted when new DIABETIC PERIPHERAL NEUROPATHIC PAIN trials appear
Sign up with your email to follow new studies for DIABETIC PERIPHERAL NEUROPATHIC PAIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for diabetic nerve pain: phase 3 trial launches
Symptom relief Recruiting nowThis study tests a new medicine called suzetrigine for people with nerve pain from diabetes. About 1,100 adults with diabetic peripheral neuropathy will receive either suzetrigine, a placebo, or an active comparator to see if it safely reduces pain over 12 weeks. The goal is to f…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New pill could ease diabetic nerve pain in landmark trial
Symptom relief Recruiting nowThis Phase 2 trial tests an experimental oral drug called VX-993 for pain caused by diabetic peripheral neuropathy, a common complication of diabetes. About 300 adults with type 1 or type 2 diabetes and nerve pain in both legs for at least a year will receive VX-993, pregabalin (…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New pill could ease diabetic nerve pain without opioids
Symptom relief Recruiting nowThis phase 3 trial tests suzetrigine, an experimental oral drug, for pain caused by diabetic peripheral neuropathy. About 734 adults with diabetes and nerve pain in their legs for at least a year will receive either the drug or a placebo. The main goal is to see if suzetrigine re…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New pill HRS-2129 aims to ease diabetic nerve pain
Symptom relief Recruiting nowThis study tests a new drug called HRS-2129 in 168 Chinese adults with diabetic peripheral neuropathic pain (nerve pain from diabetes). Participants will receive either HRS-2129, a placebo, or the standard drug pregabalin to see if HRS-2129 reduces pain better than placebo. The t…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New hope for diabetic nerve pain: experimental drug enters phase 2 trial
Symptom relief Recruiting nowThis study tests whether a new drug called LY4065967 can safely reduce nerve pain in people with diabetes. About 150 adults with diabetic nerve pain in their legs for at least 6 months will receive either the study drug or a placebo. The main goal is to see if the drug lowers ave…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC